Literature DB >> 10710107

Does administration of infliximab increase susceptibility to listeriosis?

J Morelli, F A Wilson.   

Abstract

Mesh:

Substances:

Year:  2000        PMID: 10710107     DOI: 10.1111/j.1572-0241.2000.01872.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


× No keyword cloud information.
  14 in total

Review 1.  Listeria endocarditis in a patient with psoriatic arthritis on infliximab: are biologic agents as treatment for inflammatory arthritis increasing the incidence of Listeria infections?

Authors:  Theodoros Kelesidis; Amandeep Salhotra; Jorge Fleisher; Daniel Z Uslan
Journal:  J Infect       Date:  2010-02-20       Impact factor: 6.072

Review 2.  Pneumocystis carinii pneumonia with oral candidiasis after infliximab therapy for Crohn's disease.

Authors:  Nirmal Kaur; Thomas C Mahl
Journal:  Dig Dis Sci       Date:  2004-09       Impact factor: 3.199

3.  Septicemic listeriosis during adalimumab- and golimumab-based treatment for ulcerative colitis: case presentation and literature review.

Authors:  Ryoko Horigome; Hiroki Sato; Terasu Honma; Shuji Terai
Journal:  Clin J Gastroenterol       Date:  2019-06-20

Review 4.  Canadian Association of Gastroenterology Clinical Practice Guidelines: The use of tumour necrosis factor-alpha antagonist therapy in Crohn's disease.

Authors:  D C Sadowski; C N Bernstein; A Bitton; K Croitoru; R N Fedorak; A Griffiths
Journal:  Can J Gastroenterol       Date:  2009-03       Impact factor: 3.522

5.  Listeriosis in patients receiving biologic therapies.

Authors:  M Bodro; D L Paterson
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-04-09       Impact factor: 3.267

Review 6.  Listeria meningitis complicating a patient with ulcerative colitis on concomitant infliximab and hydrocortisone.

Authors:  V Parihar; S Maguire; A Shahin; Z Ahmed; M O'Sullivan; M Kennedy; C Smyth; R Farrell
Journal:  Ir J Med Sci       Date:  2015-09-10       Impact factor: 1.568

Review 7.  Nocardia infections among immunomodulated inflammatory bowel disease patients: A review.

Authors:  Cândida Abreu; Nuno Rocha-Pereira; António Sarmento; Fernando Magro
Journal:  World J Gastroenterol       Date:  2015-06-07       Impact factor: 5.742

8.  Cutaneous nocardiosis complicating management of Crohn's disease with infliximab and prednisone.

Authors:  Sheldon M Singh; Neil V Rau; Lawrence B Cohen; Howard Harris
Journal:  CMAJ       Date:  2004-10-26       Impact factor: 8.262

9.  Listeria meningitis complicating infliximab treatment for Crohn's disease.

Authors:  Geoffrey Williams; Asad A Khan; Franzjosef Schweiger
Journal:  Can J Infect Dis Med Microbiol       Date:  2005-09       Impact factor: 2.471

Review 10.  Neurological disorders and inflammatory bowel diseases.

Authors:  Giovanni Casella; Gian Eugenio Tontini; Gabrio Bassotti; Luca Pastorelli; Vincenzo Villanacci; Luisa Spina; Vittorio Baldini; Maurizio Vecchi
Journal:  World J Gastroenterol       Date:  2014-07-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.